LEVERAGE SHORT - ALMIRALL Share Price

Certificat

Z0655

DE000SH2TQN5

Real-time Bid/Ask 07:03:30 20/05/2024 pm IST
1.03 EUR / 1.05 EUR -7.14% Intraday chart for LEVERAGE SHORT - ALMIRALL
Current month-34.88%
1 month-48.15%
Date Price Change
17/24/17 1.12 -1.75%
16/24/16 1.14 0.00%
15/24/15 1.14 -10.24%
14/24/14 1.27 +9.48%
13/24/13 1.16 -12.12%

Delayed Quote BME

Last update May 17, 2024 at 09:00 pm IST

More quotes

Static data

Product typeWarrant Esotici e Strutturati
Buy / SellPUT
Underlying ALMIRALL, S.A.
IssuerLogo Issuer Société Générale Société Générale
Z0655
ISINDE000SH2TQN5
Date issued 25/02/2022
Maturity Unlimited
Parity 1 : 1
Emission price 5.04
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.3
Lowest since issue 1.12
Spread 0.03
Spread %2.83%

Company Profile

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Sector
-
More about the company

Ratings for Almirall, S.A.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Almirall, S.A.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
9.27 EUR
Average target price
11.28 EUR
Spread / Average Target
+21.65%
Consensus
  1. Stock Market
  2. Certificates
  3. Z0655 Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW